Breast Cancer during pregnancy

Breast cancer during pregnancy is a rare but challenging condition, affecting about 1 in 3,000 pregnancies. Diagnosing breast cancer during pregnancy requires balancing the need for prompt treatment with the safety of the developing fetus. Treatment approaches depend on the stage of pregnancy and cancer, aiming to achieve the best possible outcomes for both mother and baby. Options may include surgery, chemotherapy (often delayed until after the first trimester), radiation therapy (carefully targeted to minimize fetal exposure), and hormone therapy (used cautiously due to potential effects on the fetus). Multidisciplinary teams coordinate care to optimize treatment decisions while supporting maternal and fetal health. Research continues to explore optimal management strategies and outcomes for pregnant women with breast cancer, emphasizing personalized approaches and shared decision-making between healthcare providers and patients.

    Related Conference of Breast Cancer during pregnancy

    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Paris, France
    August 18-19, 2025

    6th Cancer Diagnostics & Treatment Conference

    Rome, Italy
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    October 22-23, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    October 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    Zurich, Switzerland
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain
    March 23-24, 2026

    16th World Congress on Breast Cancer Research & Therapies

    Aix-en-Provence, France

    Breast Cancer during pregnancy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in